{"id":"W2947306414","doi":"10.1200/jco.2019.37.15_suppl.tps3166","title":"A phase Ia/Ib, open label, multicenter, dose-escalation study of BI 907828 (MDM2-p53 antagonist) in adult patients with advanced or metastatic solid tumors.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Tolerability; Pharmacodynamics; Pharmacokinetics; Cancer; Mdm2; Oncology; Internal medicine; Clinical trial; Phases of clinical research; Primary tumor; Pharmacology; Metastasis; Adverse effect; Apoptosis; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001383451,0.002208176,0.002030459,0.0006155314,0.0004553589,0.0009174358,0.000912077,0.001147408,0.004544563],"category_scores_gemma":[0.0007736377,0.000711147,0.0009016361,0.0005908948,0.000785834,0.0009267834,0.0004337983,0.003493607,0.001876016],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009706041,"about_ca_system_score_gemma":0.001676691,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009947887,"about_ca_topic_score_gemma":0.002007826,"domain_scores_codex":[0.9995281,0.0001835974,0.00002798799,0.00009167671,0.00004772505,0.0001209361],"domain_scores_gemma":[0.9991973,0.00006858859,0.0001597506,0.00005920194,0.00005555708,0.0004596973],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6154968,0.1352027,0.008336518,0.0009647008,0.001007786,0.0004231931,0.0005510322,0.003684788,0.08992999,0.0004503304,0.01065881,0.1332934],"study_design_scores_gemma":[0.4410918,0.5353754,0.01230941,0.0000396167,0.0002711012,0.0005085354,0.00008307071,0.001137496,0.004146273,0.0003048707,0.004700019,0.00003242911],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848436,0.002360054,0.0009722614,0.0007296987,0.0001415841,0.005082656,0.002574929,0.0002632051,0.00303202],"genre_scores_gemma":[0.9790521,0.002096795,0.003167236,0.001618158,0.0001736023,0.004931539,0.005096856,0.00007146902,0.003792469],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004544563,"threshold_uncertainty_score":0.01520306,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09282442175627433,"score_gpt":0.4955097842812617,"score_spread":0.4026853625249874,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}